LSD - OPEN Foundation

Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges

Majić, T., Jungaberle, H., Schmidt, T. T., Zeuch, A., Hermle, L., & Gallinat, J. | Fortschritte der Neurologie-Psychiatrie | 2 August 2017

Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways

López-Giménez, J. F., & González-Maeso, J. | Current Topics in Behavioral Neuroscience | 5 July 2017

The Effects of Hallucinogens on Gene Expression

Martin, D. A., & Nichols, C. D. | Current Topics in Behavioral Neurosciences | 5 July 2017

LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark

Larsen, J. K. | Nordic Journal of Psychiatry | 5 July 2017

Humanistic Psychology, Psychedelics, and the Transpersonal Vision

Grob, C. S., & Bossis, A. | Journal of Humanistic Psychology | 1 July 2017

LSD experiments by the United States Army

Ross, C. A. | History of Psychiatry | 1 July 2017

A Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (HTR2A) or Early Growth Response Genes (EGR1-3) in Healthy Subjects

Dolder, P. C., Grünblatt, E., Müller, F., Borgwardt, S. J., & Liechti, M. E. | Frontiers in Pharmacology | 28 June 2017

Dreams and psychedelics: neurophenomenological comparison and therapeutic implications

Kraehenmann, R. | Current neuropharmacology | 18 June 2017

Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775)

Brandt, S. D., Kavanagh, P. V., Twamley, B., Westphal, F., Elliott, S. P., Wallach, J., ... & Halberstadt, A. L. | Drug Testing and Analysis | 5 June 2017

Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness

Forstmann, M., & Sagioglou, C. | Journal of Psychopharmacology | 1 June 2017

Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial

Dolder, P. C., Liechti, M. E., & Rentsch, K. M. | Journal of Clinical Laboratory Analysis | 26 May 2017

Looking for the Self: Phenomenology, Neurophysiology and Philosophical Significance of Drug-induced Ego Dissolution

Millière, R. | Frontiers in Human Neuroscience | 23 May 2017

Changes in Resting-State Global Brain Connectivity in LSD-Induced Altered States of Consciousness are Attributable to the 5-HT2A Receptor

Preller, K., Schleifer, C., Stämpfli, P., Krystal, J., Vollenweider, F., & Anticevic, A. | Biological Psychiatry | 29 April 2017

Modern Clinical Research on LSD

Liechti, M. E. | Neuropsychopharmacology | 27 April 2017

Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin

Schartner, M. M., Carhart-Harris, R. L., Barrett, A. B., Seth, A. K., & Muthukumaraswamy, S. D. | Scientific Reports | 19 April 2017

Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects

Mueller, F., Lenz, C., Dolder, P. C., Harder, S., Schmid, Y., Lang, U. E., ... & Borgwardt, S. | Translational Psychiatry | 4 April 2017

Psychoactive Drugs as a Route to Development of Novel Anti-parasitic Agents

Woodhouse, K., Chan, J. D., & Marchant, J. | The FASEB Journal | 1 April 2017

An online survey of tobacco smoking cessation associated with naturalistic psychedelic use

Johnson, M. W., Garcia-Romeu, A., Johnson, P. S., & Griffiths, R. R. | Journal of Psychopharmacology | 18 January 2017

LSD instead of 25I-NBOMe: The revival of LSD? A case report

Bodeau, S., Bennis, Y., Régnaut, O., Fabresse, N., Richeval, C., Humbert, L., ... & Lemaire-Hurtel, A. S. | Toxicologie Analytique et Clinique | 27 February 2017

Hallucinogenic Drugs: A New Study Answers Old Questions about LSD

Halberstadt, A. L. | Current Biology | 20 February 2017

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects

Dolder, P. C., Schmid, Y., Steuer, A. E., Kraemer, T., Rentsch, K. M., Hammann, F., & Liechti, M. E. | Clinical Pharmacokinetics | 14 February 2017

Disrupted integration of sensory stimuli with information about the movement of the body as a mechanism explaining LSD-induced experience

Juszczak, G. R. | Medical Hypotheses | 3 February 2017